Pui-Kai Li

Mechanistic Insights into the Allosteric Inhibition of Androgen Receptors by Binding Function 3 Antagonists from an Integrated Molecular Modeling Study

Xiaolin Cheng, Xiaotian Kong, Enming Xing, 2021, J. Chem. Inf. Model..

A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities

Dan L Sackett, Pui-Kai Li, D. Sackett, 2006, Molecular Cancer Therapeutics.

Abstract 933: The expression of PRMT5 methyltransferase mediates cell survival and metastatic phenotype in malignant melanoma

Fengting Yan, Pui-Kai Li, Chenglong Li, 2011 .

Biochemical and pharmacological development of steroidal inhibitors of aromatase

Pui-Kai Li, R. Brueggemeier, Pui-Kai Li, 1990, The Journal of Steroid Biochemistry and Molecular Biology.

Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416.

Ping Chen, Dan L Sackett, Pui-Kai Li, 2006, Bioorganic & medicinal chemistry.

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.

Donald J Buchsbaum, Pui-Kai Li, Yonghe Li, 2014, Cancer letters.

Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide

Guido Marcucci, Christoph Plass, Pui-Kai Li, 2009, Journal of Pharmacology and Experimental Therapeutics.

Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.

Pui-Kai Li, Li Lin, S. Kulp, 2010, Cancer research.